Neumora Therapeutics
2 known investors
Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
BiotechDeep TechDigital HealthMedical Devices
Investors · 2
In the news
- Neumora Therapeutics Target of Unusually Large Options Trading (NASDAQ:NMRA) - Daily Politicaldailypolitical.com · 2026
- NMRA Stock Drops As Neumora Axes Failed Depression Drugtimothysykes.com · 2026
- With 43% ownership, Neumora Therapeutics, Inc. (NASDAQ:NMRA) has piqued the interest of institutional investorsfinance.yahoo.com · 2025
- Neumora Raises Additional $112M to Advance Neuro Pipeline (Updated) - BioSpacebiospace.com · 2022
- Neumora Therapeutics Announces $112 Million Series B Financingbusinesswire.com · 2022
- How To Invest In Neumora Therapeutics, Inc. Stock - NMRA Share Price Today & News | Stashstash.com